Arkolith/Insider Trading/PCRX/Form 4

Teehan Brendan

Chief Commercial OfficerPacira BioSciences, Inc. (PCRX) · full profile →Form 4 · filed Feb 4, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 1, 2025Grant(A)54K—$054K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 4, 2025Grant(A)100K$26.59$2.6M100K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001396814-25-000030) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML